Rhapsogen is a biotechnology and immunology company founded in early 2025 and based in Cambridge, Massachusetts, focused on redefining treatments for autoimmune diseases.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Rhapsogen →Already a subscriber? Sign in
Xcout Intel tracks Rhapsogen continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at Rhapsogen? Claim this profile